Silexion Therapeutics Corp
SLXN
$3.78
$0.051.34%
NASDAQ
| 12/31/2024 | 09/30/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | -281.79% | 1,405.84% | -77.39% | ||
| Total Depreciation and Amortization | -300.00% | 120.00% | -46.67% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 351.37% | -867.47% | -154.61% | ||
| Change in Net Operating Assets | -320.23% | -1,620.00% | -- | ||
| Cash from Operations | -132.78% | -287.30% | -92.32% | ||
| Capital Expenditure | 100.00% | -166.67% | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | 100.00% | -122.22% | -101.18% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -- | -- | -- | ||
| Foreign Exchange rate Adjustments | -111.70% | 137.88% | -394.74% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 35.48% | 140.65% | -371.17% | ||